United-Guardian entered into manufacturing & supply agreement with Amsino for Renacidin Irrigation

UNITED GUARDIAN INC

Agreement with Amsino Healthcare (USA) effective Jan 1, 2023 for manufacture and supply of Renacidin Irrigation.
Initial term of 6 years with automatic renewal for two successive 2-year periods.
Company will supply raw materials; Amsino manufactures, tests, releases, and ships product.
Customary provisions for regulatory compliance, quality control, indemnification, confidentiality.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

UNITED GUARDIAN INC entered into Manufacturing and Supply Agreement with Amsino Healthcare (USA), Inc. (effective 2023-03-30).

Action: entry
Agreement: supply
Counterparty: Amsino Healthcare (USA), Inc.
Effective: 2023-03-30

Exact text from the filing

On March 30, 2023, United-Guardian, Inc. (the “Company”) entered into a manufacturing and supply agreement with Amsino Healthcare (USA), Inc. (“Amsino”), the successor in interest to Smiths Medical, effective as of January 1, 2023 (the “Agreement”).

View on SEC.gov

737 material agreements filed in the last 30 days. Browse all material agreements →

UNITED GUARDIAN INC filing history →

Source: SEC EDGAR

accession 0001171843-24-001119

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.